ASPEN AEROGELS ($ASPN) posted quarterly earnings results on Thursday, August 7th. The company reported earnings of -$0.04 per share, beating estimates of -$0.09 by $0.05. The company also reported revenue of $78,020,000, beating estimates of $73,976,081 by $4,043,919.
You can see Quiver Quantitative's $ASPN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ASPEN AEROGELS Insider Trading Activity
ASPEN AEROGELS insiders have traded $ASPN stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ASPN stock by insiders over the last 6 months:
- DONALD R YOUNG (President and CEO) purchased 20,000 shares for an estimated $107,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ASPEN AEROGELS Hedge Fund Activity
We have seen 119 institutional investors add shares of ASPEN AEROGELS stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAGNON SECURITIES LLC added 1,899,108 shares (+inf%) to their portfolio in Q2 2025, for an estimated $11,242,719
- CUBIST SYSTEMATIC STRATEGIES, LLC removed 1,248,979 shares (-89.6%) from their portfolio in Q1 2025, for an estimated $7,980,975
- AWM INVESTMENT COMPANY, INC. added 1,240,535 shares (+102.6%) to their portfolio in Q1 2025, for an estimated $7,927,018
- POINT72 ASSET MANAGEMENT, L.P. removed 1,104,549 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $7,058,068
- AMERICAN CENTURY COMPANIES INC removed 1,003,184 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $6,410,345
- UNISUPER MANAGEMENT PTY LTD removed 848,287 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $5,420,553
- ALYESKA INVESTMENT GROUP, L.P. removed 800,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $5,112,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ASPEN AEROGELS Analyst Ratings
Wall Street analysts have issued reports on $ASPN in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B. Riley Securities issued a "Buy" rating on 02/19/2025
- Canaccord Genuity issued a "Buy" rating on 02/14/2025
- Craig-Hallum issued a "Buy" rating on 02/14/2025
- Roth MKM issued a "Buy" rating on 02/14/2025
To track analyst ratings and price targets for ASPEN AEROGELS, check out Quiver Quantitative's $ASPN forecast page.
ASPEN AEROGELS Price Targets
Multiple analysts have issued price targets for $ASPN recently. We have seen 5 analysts offer price targets for $ASPN in the last 6 months, with a median target of $16.0.
Here are some recent targets:
- David Anderson from Barclays set a target price of $7.0 on 05/29/2025
- Ryan Pfingst from B. Riley Securities set a target price of $22.0 on 02/19/2025
- Eric Stine from Craig-Hallum set a target price of $18.0 on 02/14/2025
- Chip Moore from Roth MKM set a target price of $16.0 on 02/14/2025
- George Gianarikas from Canaccord Genuity set a target price of $15.0 on 02/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
